Literature DB >> 31032662

Low Body Mass Index Is Associated with Higher Odds of COPD and Lower Lung Function in Low- and Middle-Income Countries.

Matthew R Grigsby1,2, Trishul Siddharthan1,2, Suzanne L Pollard1,2, Muhammad Chowdhury3, Adolfo Rubinstein4, J Jaime Miranda5,6, Antonio Bernabe-Ortiz5, Dewan Alam7, Bruce Kirenga8, Rupert Jones9, Frederick van Gemert10, William Checkley1,2.   

Abstract

The relationship of body mass index (BMI) with lung function and COPD has been previously described in several high-income settings. However, few studies have examined this relationship in resource-limited settings where being underweight is more common. We evaluated the association between BMI and lung function outcomes across 14 diverse low- and middle-income countries. We included data from 12,396 participants aged 35-95 years and used multivariable regressions to assess the relationship between BMI with either COPD and lung function while adjusting for known risk factors. An inflection point was observed at a BMI of 19.8 kg/m2. Participants with BMI < 19.8 kg/m2 had a 2.28 greater odds (95% CI 1.83-2.86) of having COPD and had a 0.21 (0.13-0.30) lower FEV1 and 0.34 (0.27-0.41) lower FEV1/FVC z-score compared to those with BMI ≥ 19.8 kg/m2. The association with lung function remained even after excluding participants with COPD. Individuals with lower BMI were more likely to have COPD and had lower lung function compared to those in higher BMI. The association with lung function remained positive even after excluding participants with COPD, suggesting that being underweight may also play a role in having worse lung function.

Entities:  

Keywords:  COPD; body mass index; low and middle income countries; lung function

Mesh:

Year:  2019        PMID: 31032662     DOI: 10.1080/15412555.2019.1589443

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  6 in total

1.  Less time spent walking and depressive symptoms are associated with more self-perceived disability in primary care patients: a cross-sectional study from Uganda.

Authors:  James Mugisha; Peter Kayiira Byansi; Philip Ward; Davy Vancampfort
Journal:  Pan Afr Med J       Date:  2022-03-03

2.  The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.

Authors:  Jian-Jun Wu; Hong-Ri Xu; Ying-Xue Zhang; Yi-Xuan Li; Hui-Yong Yu; Liang-Duo Jiang; Cheng-Xiang Wang; Mei Han
Journal:  BMC Pulm Med       Date:  2020-04-23       Impact factor: 3.317

3.  Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome.

Authors:  Anthony Tam; Fernando Sergio Leitao Filho; Seung Won Ra; Julia Yang; Janice M Leung; Andrew Churg; Joanne L Wright; Don D Sin
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240

4.  Development and validation of the EHS-COPD model to predict sex-specific risk of chronic obstructive pulmonary disease (COPD) in older Chinese adults: Hong Kong's Elderly Health Service Cohort.

Authors:  Zhao Yang; C Mary Schooling; Siu Yin Lee; Man Ki Kwok
Journal:  Ann Transl Med       Date:  2022-01

5.  The effect of metabolic health and obesity on lung function: A cross sectional study of 114,143 participants from Kangbuk Samsung Health Study.

Authors:  Jonghoo Lee; Hye Kyeong Park; Min-Jung Kwon; Soo-Youn Ham; Si-Young Lim; Jae-Uk Song
Journal:  PLoS One       Date:  2022-04-13       Impact factor: 3.240

Review 6.  High-Density Lipoproteins: A Role in Inflammation in COPD.

Authors:  Stanislav Kotlyarov
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.